These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7652776)

  • 1. Skin transplantation--experimental basis for the study of human histocompatibility.
    Rapaport FT
    Transplant Proc; 1995 Aug; 27(4):2205-10. PubMed ID: 7652776
    [No Abstract]   [Full Text] [Related]  

  • 2. Local immune states in ABO-incompatible renal allografts.
    Yamashita M; Aikawa A; Ohara T; Kawamura S; Nagamine K; Hasegawa A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):274-6. PubMed ID: 8438298
    [No Abstract]   [Full Text] [Related]  

  • 3. The experimental skin allograft in man.
    Rapaport FT; Converse JM; Dausset J
    Transplant Proc; 1980 Dec; 12(4):621-5. PubMed ID: 7010723
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody-mediated rejection of an HLA-identical, ABO-incompatible kidney transplant after two failed cadaver transplants.
    Fryer JP; Benedetti E; Perry EH; Matas AJ
    Transplantation; 1994 Sep; 58(6):723-5. PubMed ID: 7940694
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity of the ABO antigen system as a determinant of histocompatibility in human transplantation.
    Rapaport FT; Dausset J
    Transplant Proc; 1987 Dec; 19(6):4487-91. PubMed ID: 3321605
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of class I and class II alloantigens on skin allograft acceptance by lethally irradiated rats repopulated with syngeneic bone marrow.
    Schwadron RB; Dittmer JE; Hartnett LC
    Transplantation; 1985 May; 39(5):558-60. PubMed ID: 3887696
    [No Abstract]   [Full Text] [Related]  

  • 7. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histocompatibility antigens and autoimmune diseases].
    Pérez González J; Sarriá A; Legido A; Ventura P; Larrad L
    An Esp Pediatr; 1985 Aug; 23(2):112-6. PubMed ID: 3864387
    [No Abstract]   [Full Text] [Related]  

  • 9. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM; Odling KA; Muller HK
    Cell Immunol; 1993 Oct; 151(2):291-9. PubMed ID: 8402936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful living donor kidney transplantation across HLA and ABO incompatibilities.
    Magee CC; Mah H; Tinckam K; Wood I; Ji F; Powelson J
    Nephrol Dial Transplant; 2007 Feb; 22(2):602-4. PubMed ID: 17132704
    [No Abstract]   [Full Text] [Related]  

  • 11. Humoral immunity in kidney transplantation: what clinicians need to know. Preface.
    Remuzzi G; Chiaramonte S; Perico N; Ronco C
    Contrib Nephrol; 2009; 162():vii-ix. PubMed ID: 19174859
    [No Abstract]   [Full Text] [Related]  

  • 12. Present status of ABO-incompatible kidney transplantation in Japan.
    Takahashi K; Saito K
    Xenotransplantation; 2006 Mar; 13(2):118-22. PubMed ID: 16623804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of HLA class II antigens/genes in xenogeneic iso, allo, and xeno transplantation.
    Tsuji K; Hagihara M; Sato T; Shimura T; Takebe K; Munkhbat B
    Transplant Proc; 1994 Aug; 26(4):2441-3. PubMed ID: 8066801
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of interferon alpha in allograft rejection.
    Benizri EJ; Gugenheim J; Bernard G; Tovey MG
    Transplant Proc; 1995 Feb; 27(1):413. PubMed ID: 7879043
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow transplantation with major ABO incompatibility. Experience of the Bone Marrow Transplantation Unit--Francisco Gentil Portuguese Institute of Oncology, Lisbon Centre.
    Coelho R; Cunha I; Nolasco I; Machado A; Abecassis M
    Acta Med Port; 1994 Dec; 7 Suppl 1():S21-4. PubMed ID: 7653275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunity and erythematodes. II. Histocompatibility of experimental skin homografts in patient affected by erythematodes and blood groups].
    Leigheb G; Visetti M; Albertazzi F
    Minerva Dermatol; 1967 Sep; 42(9):450-4. PubMed ID: 4895724
    [No Abstract]   [Full Text] [Related]  

  • 17. HLA 1992: typing strategies and perspectives in bone marrow transplantation.
    Charron DJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):171-2. PubMed ID: 8438262
    [No Abstract]   [Full Text] [Related]  

  • 18. Histocompatibility antigens.
    Daunter B; Mackay EV
    Aust N Z J Obstet Gynaecol; 1983 Nov; 23(4):231-6. PubMed ID: 6324735
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching.
    Reinhard T; Böhringer D; Enczmann J; Kögler G; Mayweg S; Wernet P; Sundmacher R
    Eye (Lond); 2004 Mar; 18(3):269-77. PubMed ID: 15004576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological role and the clinical significance of the HLA histocompatibility system].
    Zaretskaia IuM
    Vestn Akad Med Nauk SSSR; 1979; (7):71-6. PubMed ID: 395790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.